ZAHARA Risk Score Calculator

Clinical calculation support · Verify results before clinical use

Maternal Cardiac Risk Assessment

Select each clinical feature present before pregnancy. The score updates automatically.

0.00Total score
01

History of arrhythmias

A documented history of cardiac arrhythmia.

+1.50 points
02

Cardiac medication before pregnancy

Use of cardiovascular medication before pregnancy.

+1.50 points
03

NYHA functional class ≥ II

NYHA class II, III, or IV before pregnancy.

+0.75 points
04

Left heart obstruction

Severe obstruction; the original score describes peak gradient >50 mmHg or aortic valve area <1.0 cm².

+2.50 points
05

Systemic AV valve regurgitation

Moderate or severe systemic atrioventricular valve regurgitation.

+0.75 points
06

Pulmonary (subpulmonary) AV valve regurgitation

Moderate or severe subpulmonary atrioventricular valve regurgitation.

+0.75 points
07

Mechanical valve prosthesis

Presence of a mechanical heart valve prosthesis.

+4.25 points
08

Cyanotic congenital heart disease

Corrected or uncorrected cyanotic congenital heart disease, as defined in the score's source population.

+1.00 point
0.00ZAHARA
Estimated maternal cardiac complication risk
Lowest score category
2.9% estimated event rate in the derivation cohort
InterpretationThe score is a risk-stratification aid and should be interpreted alongside lesion-specific assessment and the modified WHO pregnancy risk classification.

This percentage represents the event rate reported for the score category in the original cohort, not an individualized guarantee or a substitute for specialist assessment.

About the ZAHARA Score

The ZAHARA (Zwangerschap bij Aangeboren HARtAfwijking) score was developed to estimate maternal cardiac complications during pregnancy in women with congenital heart disease. It assigns predictor-specific weights rather than one point value for every factor.

Predictors and weights

PredictorCriterionPoints
History of arrhythmiasPresent1.50
Cardiac medication before pregnancyUsed1.50
NYHA functional classClass ≥ II0.75
Left heart obstructionPeak gradient >50 mmHg or aortic valve area <1.0 cm²2.50
Systemic AV valve regurgitationModerate / severe0.75
Subpulmonary AV valve regurgitationModerate / severe0.75
Mechanical valve prosthesisPresent4.25
Cyanotic congenital heart diseaseCorrected or uncorrected1.00

Reported maternal cardiac complication rates

Total scoreReported risk
0–0.502.9%
0.51–1.507.5%
1.51–2.5017.5%
2.51–3.5043.1%
>3.5070.0%

Published summaries sometimes differ in how they print category boundaries (for example, >3.50 versus ≥3.51). The calculator applies the reported categories to the score values generated by these weights.

Clinical notes & references

Use this score in the intended population: pregnant women with congenital heart disease. The score does not replace comprehensive pre-pregnancy counselling, assessment by a Pregnancy Heart Team, or lesion-specific recommendations.

Important limitations

  • It estimates risk at a group level and may not be calibrated identically across populations.
  • Do not use the score alone to determine pregnancy eligibility or management.
  • Confirm clinical definitions and severity of valve regurgitation and obstruction from the original protocol and current specialist guidance.

References

Drenthen W, Boersma E, Balci A, et al.Predictors of pregnancy complications in women with congenital heart disease. European Heart Journal. 2010;31(17):2124–2132. doi:10.1093/eurheartj/ehq200
High-Risk Congenital Heart Disease in Pregnancy.Review summarizing ZAHARA predictors and reported event rates. Cardiology Clinics / PMC. Full text at PubMed Central
European Society of Cardiology (ESC).Pregnancy risk assessment and congenital heart disease risk tools. Use current ESC guidance and specialist multidisciplinary assessment when making clinical decisions.
Clinical disclaimer: This calculator is intended for clinical education and decision support. It does not replace individual clinical judgement, current guidelines, or multidisciplinary specialist care. Maternal and fetal risk assessment should include the modified WHO classification and evaluation of the underlying congenital lesion.